Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LDHA | P00338 | 1/20 | 0.48 |
| ▸ | CDK1 | P06493 | 1/20 | 0.47 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.47 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.46 |
| ▸ | TLR4 | O00206 | 1/20 | 0.41 |
| ▸ | LY96 | Q9Y6Y9 | 1/20 | 0.41 |
| ▸ | AKT1 | P31749 | 1/20 | 0.41 |
| ▸ | PRKCA | P17252 | 4/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL33763 | 1.00 | LDHA (0.48) | LDHACDK1CCNB1EPHX2TLR4 | |
| SCHEMBL359292 | 1.00 | LDHA (0.48) | LDHACDK1CCNB1EPHX2TLR4 | |
| SCHEMBL359134 | 1.00 | LDHA (0.48) | LDHACDK1CCNB1EPHX2TLR4 | |
| SCHEMBL16253 | 1.00 | LDHA (0.48) | LDHACDK1CCNB1EPHX2TLR4 | |
| SCHEMBL15435964 | 1.00 | LDHA (0.48) | LDHACDK1CCNB1EPHX2TLR4 | |
| SCHEMBL337163 | 1.00 | LDHA (0.48) | LDHACDK1CCNB1EPHX2TLR4 | |
| SCHEMBL313538 | 1.00 | LDHA (0.48) | LDHACDK1CCNB1EPHX2TLR4 | |
| SCHEMBL128339 | 1.00 | LDHA (0.48) | LDHACDK1CCNB1EPHX2TLR4 | |
| SCHEMBL359493 | 1.00 | LDHA (0.48) | LDHACDK1CCNB1EPHX2TLR4 | |
| SCHEMBL271582 | 1.00 | LDHA (0.48) | LDHACDK1CCNB1EPHX2TLR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 12728 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12636251-B1 | Glycoside-containing aqueous formulations having a lipophilic active component | Doane Technology Group LLC (US) | 2026-05-26 | — | — | US | claimed |
| EP-3785708-B1 | FILM-FORMING COMPOSITION CONTAINING SURFACTANT OR SURFACTANT AND SALT AS WHITENING AGENT | CAPSUGEL BELGIUM NV (BE) | 2026-05-20 | — | — | EP | claimed |
| CN-114763366-B | Sucrose fatty acid ester with high monoester content and preparation method thereof | 四川科伦药物研究院有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-122005341-A | Safe sun-proof microcapsule coating composition, microcapsule coating method, cosmetic and application | 广州诺元生物科技有限公司 | 2026-05-12 | — | — | CN | claimed |
| EP-4732834-A2 | FILM-FORMING COMPOSITION CONTAINING SURFACTANT OR SURFACTANT AND SALT AS WHITENING AGENT | Capsugel Belgium NV (BE) | 2026-04-29 | — | — | EP | claimed |
| EP-4414063-B1 | NANONETS FOR REMOVAL OF CONTAMINANTS FROM AQUEOUS SOLUTIONS, KITS THEREFOR AND METHODS OF THEIR USE | CARBONET NANOTECHNOLOGIES INC (CA) | 2026-04-15 | — | — | EP | claimed |
| US-20260083756-A1 | Capsules With Self-Emulsifying Drug Delivery Systems | FERTIN PHARMA A/S (DK) | 2026-03-26 | — | — | US | claimed |
| US-20260076950-A1 | USE OF A PHOSPHODIESTERASE 10 INHIBITOR FOR THE TREATMENT OF TOURETTE SYNDROME | NOEMA PHARMA AG (CH) | 2026-03-19 | — | — | US | claimed |
| US-20260048018-A1 | PROCESS FOR THE MANUFACTURE OF A SOLID PHARMACEUTICAL ADMINISTRATION FORM | MERCK PATENT GMBH (DE) | 2026-02-19 | — | — | US | claimed |
| EP-4687974-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING ANTIBODIES BINDING TO CD30 AND CD3 | Genmab A/S (DK) | 2026-02-11 | — | — | EP | claimed |
| US-4259202-A | MONOESTER OF SACCHAROSE WITH FATTY ACID | TOYO CONTACT LENS CO., LTD. (JP) | 1981-03-31 | — | — | US | claimed |
| US-4150114-A | ENHANCED PENETRATION | THE PROCTER & GAMBLE COMPANY (US) | 1979-04-17 | — | — | US | claimed |
| US-4148893-A | SUGAR ESTER AND DIALKYL SULFOXIDE ENHANCE PENETRATION THROUGH SKIN | THE PROCTER & GAMBLE COMPANY (US) | 1979-04-10 | — | — | US | claimed |
| US-4148924-A | Dermatological compositions | THE PROCTER & GAMBLE COMPANY (US) | 1979-04-10 | — | — | US | claimed |
| US-4148917-A | PENETRATION | THE PROCTER & GAMBLE COMPANY (US) | 1979-04-10 | — | — | US | claimed |
| US-4148874-A | ENHANCE PENETRATION OF PHARMOCOLOGICALLY ACTIVE AGENTS THROUGH THE SKIN | THE PROCTER & GAMBLE COMPANY (US) | 1979-04-10 | — | — | US | claimed |
| US-4148887-A | SUGAR ESTER WITH A METHYL SULFOXIDE | THE PROCTER & GAMBLE COMPANY (US) | 1979-04-10 | — | — | US | claimed |
| US-4130667-A | A SUCROSE ESTER AND A PHOSPHINE OXIDE | THE PROCTER & GAMBLE COMPANY (US) | 1978-12-19 | — | — | US | claimed |
| US-4130643-A | STEROID, SUCROSE ESTER, SULFOXIDE | THE PROCTER & GAMBLE COMPANY (US) | 1978-12-19 | — | — | US | claimed |
| US-4046886-A | SUGAR ESTER, PHOSPHINE OXIDE | THE PROCTER & GAMBLE COMPANY (US) | 1977-09-06 | — | — | US | claimed |